Literature DB >> 2912706

The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. V. Interaction between the db gene and hepatic sex steroid sulfotransferases correlates with gender-dependent susceptibility to hyperglycemia.

E H Leiter1, H D Chapman, D L Coleman.   

Abstract

Steroid sulfurylation represents a potential mechanism for controlling the level of active steroids within a tissue. We have elucidated an inbred strain background-dependent interaction between the diabetes (db) mutation and steroid sulfotransferase (ST) enzymes, potentially modulating the level of active steroid hormones or their precursors in the liver. Gonadectomized mutants were analyzed to correlate how strain- and gender-dependent variation in ST activities interacted with db to achieve diabetogenesis. Both sexes on the C57BL/KsChp (BKs) background developed severe early-onset hyperglycemia, and gonadectomy failed to prevent diabetes. In contrast, C3HeB/FeChp (C3HeB)-db/db males, but not females, were diabetes susceptible, and the male susceptibility was completely dependent upon endogenous testes-derived testosterone. The female resistance, in turn, was dependent upon ovarian sex steroids. The differential requirements of BKs- and C3HeB-db/db males and females for gonadal sex steroids could be explained on the basis of the differential strength of the interaction between the db mutation and hepatic ST activities. Hepatic ST from normal adult females sulfurylated dehydroepiandrosterone (DHEA), whereas this activity disappeared in cytosols of normal adult males by 8 weeks of age. This sexually dimorphic inability to sulfurylate (pre)androgens was controlled by testosterone. Diabetogenic susceptibility in BKs mutant mice of both sexes was associated with marked depression of preandrogen/androgen sulfurylation [female mutants exhibiting at least a 5-fold reduced DHEA sulfurylation at a near-physiological concentration (0.2 microM)]. This reduced preandrogen/androgen sulfurylation occurred concomitant with a 10-fold acceleration of estrone (E1) sulfurylation at a limiting (0.2 microM) concentration, essentially producing a hyperandrogenized hepatic tissue state. These extreme shifts in ST substrate preferences were not observed in the diabetes-resistant C3HeB-db/db females. Kinetic analysis of semipurified hepatic ST from BKs-db/db females showed a 10-fold decrease in Km for E1 (apparent Km = 0.9 microM in mutants vs. 9.0 microM in normals). Whereas the Km for DHEA did not differ from the control value, hepatic ST from BKs-db/db females showed a 10-fold decreased maximal velocity for DHEA sulfurylation (1230 vs. 12750 pmol/mg.h in control preparations). The antihyperglycemic effects of dietary E1 therapy were associated with enhanced androgen sulfurylation in BKs-db/db females and restoration of androgen sulfurylation in BKs-db/db males.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2912706     DOI: 10.1210/endo-124-2-912

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  A susceptibility gene for kidney disease in an obese mouse model of type II diabetes maps to chromosome 8.

Authors:  Streamson Chua; Yifu Li; Shun Mei Liu; Ruijie Liu; Ka Tak Chan; Jeremiah Martino; Zongyu Zheng; Katalin Susztak; Vivette D D'Agati; Ali G Gharavi
Journal:  Kidney Int       Date:  2010-06-02       Impact factor: 10.612

2.  Pancreatic function in carboxyl-ester lipase knockout mice.

Authors:  Mette Vesterhus; Helge Raeder; Amarnath J Kurpad; Dan Kawamori; Anders Molven; Rohit N Kulkarni; C Ronald Kahn; Pål Rasmus Njølstad
Journal:  Pancreatology       Date:  2010-08-19       Impact factor: 3.996

3.  Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.

Authors:  C B Verchere; D A D'Alessio; R D Palmiter; G C Weir; S Bonner-Weir; D G Baskin; S E Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

4.  FTY720 normalizes hyperglycemia by stimulating β-cell in vivo regeneration in db/db mice through regulation of cyclin D3 and p57(KIP2).

Authors:  Zhengshan Zhao; Jinwoo Choi; Chunying Zhao; Zhongmin Alex Ma
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

Review 5.  Importance of oestrogen receptors to preserve functional β-cell mass in diabetes.

Authors:  Joseph P Tiano; Franck Mauvais-Jarvis
Journal:  Nat Rev Endocrinol       Date:  2012-02-14       Impact factor: 43.330

6.  Obesity-induced diabetes (diabesity) in C57BL/KsJ mice produces aberrant trans-regulation of sex steroid sulfotransferase genes.

Authors:  E H Leiter; H D Chapman
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Gender-specific expression and mechanism of regulation of estrogen sulfotransferase in adipose tissues of the mouse.

Authors:  Victor K Khor; Ming Han Tong; Yueming Qian; Wen-Chao Song
Journal:  Endocrinology       Date:  2008-07-31       Impact factor: 4.736

8.  Age- and sex-dependent expression of multiple murine hepatic hydroxysteroid sulfotransferase (SULT2A) genes.

Authors:  Thomas A Kocarek; Zhengbo Duanmu; Hai-Lin Fang; Melissa Runge-Morris
Journal:  Biochem Pharmacol       Date:  2008-08-05       Impact factor: 5.858

9.  Absence of diabetes and pancreatic exocrine dysfunction in a transgenic model of carboxyl-ester lipase-MODY (maturity-onset diabetes of the young).

Authors:  Helge Ræder; Mette Vesterhus; Abdelfattah El Ouaamari; Joao A Paulo; Fiona E McAllister; Chong Wee Liew; Jiang Hu; Dan Kawamori; Anders Molven; Steven P Gygi; Pål R Njølstad; C Ronald Kahn; Rohit N Kulkarni
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

10.  Positional cloning of "Lisch-Like", a candidate modifier of susceptibility to type 2 diabetes in mice.

Authors:  Marija Dokmanovic-Chouinard; Wendy K Chung; Jean-Claude Chevre; Elizabeth Watson; Jason Yonan; Beebe Wiegand; Yana Bromberg; Nao Wakae; Chris V Wright; John Overton; Sujoy Ghosh; Ganesh M Sathe; Carina E Ammala; Kathleen K Brown; Rokuro Ito; Charles LeDuc; Keely Solomon; Stuart G Fischer; Rudolph L Leibel
Journal:  PLoS Genet       Date:  2008-07-25       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.